Back to Company Profile

Alpha Profiles · Company Profile

GeneDx Holdings Corp.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/genedx-holdings-corp

Entity: Public listing published
Primary listing: NASDAQ: WGS
Verification: Partially verified
Last reviewed: 2026-10-08T04:45:52.591346+00:00

Overview

Alpha's canonical identity and public leadership record for GeneDx Holdings Corp..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

3 public records

Chief Operating Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001818331-26-000030Apr 30, 2026

Katherine Stueland

Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001818331-26-000030Apr 30, 2026

Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001818331-26-000030Apr 30, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Oct 8, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.

Board roles

9 public records

Chairman of the Board

Board chairIndependent

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001818331-26-000030Apr 30, 2026

Director

Independence not stated

State: confirmed
Effective: From Jan 1, 2020
Confidence: 88%
Evidence: DEF 14A wgs-20260430.htmApr 30, 2026

Director

Independence not stated

State: confirmed
Effective: From Jan 1, 2020
Confidence: 88%
Evidence: DEF 14A wgs-20260430.htmApr 30, 2026

Emily Leproust, Ph.D.

Director

Independent

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001818331-26-000030Apr 30, 2026

Director

Independence not stated

State: confirmed
Effective: From Jan 1, 2021
Confidence: 88%
Evidence: DEF 14A wgs-20260430.htmApr 30, 2026

Katherine Stueland

Chief Executive Officer and Director

Not independent

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001818331-26-000030Apr 30, 2026

Richard C. Pfenniger, Jr

Director

Independence not stated

State: confirmed
Effective: From Jan 1, 2022
Confidence: 88%
Evidence: DEF 14A wgs-20260430.htmApr 30, 2026

Director

Independence not stated

State: confirmed
Effective: From Jan 1, 2025
Confidence: 88%
Evidence: DEF 14A wgs-20260430.htmApr 30, 2026

Thomas Fuchs, Ph.D.

Director

Independent

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001818331-26-000030Apr 30, 2026

Committees

3 public records

Membership and chair roles are projected from current board seats. A chair is shown only when a stored chair flag says so.

AUDIT COMMITTEE

Chair: Keith Meister
Members: Keith Meister (Chair); Emily Leproust; Richard C. Pfenniger, Jr

Compensation Committee

Chair: Joshua Ruch
Members: Joshua Ruch (Chair); Eli Casdin; Emily Leproust

Nominating and Corporate Governance Committee

Chair: Emily Leproust
Members: Emily Leproust (Chair); Eli Casdin; Joshua Ruch

Source record

Alpha canonical company public projection

Supports Company identity, Published leadership, Entity status boundary

Reviewed 2026-10-08T04:45:52.591346+00:00